[Study of a new synthetic antibacterial agent: 8-ethyl-5-oxo-2-piperaziny 5,8-dihydro-(2,3-d)pyrimidine-6-carboxylic acid (pipemidic acid)].
D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology* / Q000633:toxicity / Q000652:urine; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D007928:Lethal Dose 50; D051379:Mice; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity / Q000652:urine; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology* / Q000633:toxicity / Q000652:urine; D051381:Rats; D018805:Sepsis
D000892:Anti-Infective Agents, Urinary; D010879:Piperazines; D011743:Pyrimidines
Etude d'un nouvel antibactérien de synthèse: l'acide éthyl-8 oxo-5 pipérazinly-2 dihydro-5,8 pyrido(2,3-pyrimidine-6 carboxylique (acide pipémidique)]